Prevention of hereditary cardiomyopathy in the syrian hamster with chronic verapamil therapy

This publication has 35 references indexed in Scilit:

• Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster
  Journal of the American College of Cardiology, 1987
• Microvascular reactivity of the myopathic Syrian hamster cremaster muscle
  Cardiovascular Research, 1987
• Increased cardiac calcium channels in hamster cardiomyopathy
  The American Journal of Cardiology, 1986
• Multiple cardiac contractile protein abnormalities in myopathic syrian hamsters (BIO 53:58)*†
  Journal of Molecular and Cellular Cardiology, 1985
• Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy
  The American Journal of Cardiology, 1985
• Sarcolemmal alterations during the development of genetically determined cardiomyopathy
  Cardiovascular Research, 1984
• Increased contractility in vascular smooth muscle of dystrophic hamsters
  Canadian Journal of Physiology and Pharmacology, 1983
• Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
  Circulation, 1982
• Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding
  Cardiovascular Research, 1981
• HEREDITARY AND ACQUIRED CARDIOMYOPATHIES IN EXPERIMENTAL ANIMALS: MECHANICAL, BIOCHEMICAL, AND STRUCTURAL FEATURES *
  Annals of the New York Academy of Sciences, 1979